By Cameron Chai
Reportlinker.com has announced the addition of a new market research report titled ‘The 2012 Japanese Flow Cytometry Markets’ to its offering.
This 142-page report covers major challenges associated with the Japanese flow cytometry practice and provides data pertaining to important technological, social, demographic, regulatory and economic trends and their impact on market over the next five years.
The comprehensive report provides forecast data in terms of sales and volumes for key flow cytometry tests conducted in commercial laboratories and hospitals in Japan during the next five-year period. It includes data pertaining to yearly placements and installed base of key flow cytometers and provides review of present instrumentation technologies. It compares the features of major systems and features five-year forecast data of instrument and reagent sales.
The in-depth report discusses market and sales shares of major instrument and reagent suppliers and reviews existing and promising diagnostic technologies and their prospective market applications. It analyzes opportunities available for product advancements in new consumables, instruments, and auxiliary products. Key flow cytometry applications covered in the report include DNA and RNA content analysis, cell cycle analysis, chemotherapy monitoring, chromosome analysis, fetal cell analysis, protein content analysis and much more.
The 15-table report provides profiles of present and up-and-coming suppliers, with data covering their sales, technological know-how, collaborative deals, new products in research and development, product portfolios, corporate strategies and marketing tactics. Companies profiled in the report include Sysmex, Siemens, Roche, Nihon Kohden, Ortho-Clinical Diagnostics, Iris, Horiba, Dako, Bio-Rad, Becton Dickinson, Beckman Coulter/Danaher, and Abbott.